An ECG monitoring lead wire device that does not require disposable electrode pads
By designing an ECG monitoring lead wire device that eliminates the need for disposable electrode pads, the electrode head and lead wire are integrally molded, integrating electrode contacts, and the adhesive patch is removable. The electrode microneedles pierce the stratum corneum of the skin, solving the problems of high consumption, high cost, and unstable signal of ECG electrode pads, and achieving low-cost, safe, and stable ECG monitoring.
Patent Information
- Application Number
- CN202611227034.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-13
- Publication Date
- 2026-11-10
AI Technical Summary
Existing ECG electrode pads are disposable, resulting in high medical costs and a large consumption of consumables. They are also prone to loosening and unstable signal acquisition when sweating or when the skin is wet, affecting the accuracy of the test.
Design an ECG monitoring lead wire device that does not require disposable electrode pads. The electrode head and lead wire are integrally molded, with integrated electrode contacts. The adhesive patch is detachable for fixation. The electrode microneedles pierce the stratum corneum of the skin and are made of titanium metal. The structural design avoids loose contact and interference from sweat.
It reduces the cost of ECG monitoring consumables, improves the stability and accuracy of signal acquisition, reduces the risk of skin allergies, is suitable for repeated use in multiple scenarios, and reduces hospital operating costs.
Smart Images

Figure CN123058741A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of medical device technology, and in particular relates to an electrocardiogram monitoring lead wire device that does not require disposable electrode pads. Background Technology
[0002] Electrocardiography (ECG) is a core non-invasive diagnostic tool for clinical screening, diagnosis of cardiovascular diseases, and real-time monitoring of patients' cardiac status. It is widely used in various medical scenarios, including routine outpatient checkups, continuous monitoring of inpatients, intraoperative vital sign monitoring, and Holter monitoring, providing crucial electrical signal data support for medical staff to assess patients' heart rhythm, myocardial status, and changes in their condition. ECG electrodes, as core consumables for ECG testing equipment, primarily work by adhering to the skin and precisely engaging with the device's ECG electrode clips to collect weak electrophysiological signals from the body surface. They are a fundamental and critical component ensuring stable ECG signals and accurate test results.
[0003] Currently, the mainstream ECG electrode pads used in clinical practice are all disposable consumables, which have the following drawbacks:
[0004] First, disposable electrode pads strictly adhere to the aseptic usage guidelines for medical consumables, being discarded and replaced after each single test or monitoring session. However, in actual clinical applications, existing disposable ECG electrode pads present significant industry pain points due to their high medical costs and large consumption of consumables. Because existing electrode pads integrate relatively expensive conductive gel, the purchase cost per conventional ECG electrode pad can reach several yuan. However, different ECG testing scenarios have specific requirements for the number of electrode pads used. A standard single ECG test requires 5 electrode pads, while scenarios such as long-term dynamic ECG monitoring, multi-lead refined ECG testing, and continuous monitoring of critically ill patients may require up to 30 electrode pads per test or monitoring session. For medical facilities with high patient volume, such as outpatient clinics, inpatient wards, intensive care units, and health check-up centers, the daily ECG testing and monitoring of a large number of patients is required. The daily consumption of electrode pads is extremely high, and the cumulative expenditure on consumables on a daily, monthly, and annual basis remains high. The long-term and large-scale consumption of consumables significantly increases the daily operation and treatment costs of medical institutions, exacerbates the medical cost burden of hospitals, and also increases the cost of medical consumables for patients to some extent. This is not conducive to the efficient and rational use of medical resources and the control of clinical treatment costs.
[0005] Secondly, existing electrode pads rely on conductive paste for conductivity. In monitoring scenarios where patients are sweating or have wet skin, the sweat will dilute the conductive paste and reduce the suction force of the suction cup. This not only makes it very easy for the electrode pads to loosen or fall off, causing monitoring interruption, but also the sweat will directly interfere with the acquisition of ECG signals from the body surface, introducing a lot of noise and significantly reducing the accuracy of ECG data.
[0006] Third, the existing electrode pads and electrode heads adopt a separate snap-fit combination scheme. The lead buckle and electrode pads are detachably connected. In practical applications, the lead buckle and electrode pads need to be frequently plugged and unplugged. Long-term repeated plugging and unplugging will cause wear and loosening of the contact points, which can easily lead to poor electrical contact and directly cause discontinuous or lost ECG signals.
[0007] Therefore, there is an urgent need to design an ECG electrode pad with optimized structure, controllable cost, adaptability to multiple clinical scenarios, and stable signal acquisition performance to solve the problems of high consumable consumption and high medical costs in existing technologies. Summary of the Invention
[0008] The purpose of this invention is to provide an electrocardiogram monitoring lead wire device that does not require disposable electrode pads, thereby solving the aforementioned technical problems.
[0009] To solve the above-mentioned technical problems, the present invention is achieved through the following technical solution.
[0010] This invention relates to an electrocardiogram (ECG) monitoring lead wire device that does not require disposable electrode pads, comprising a lead wire, an electrode head, and an adhesive patch; the electrode head is integrally formed with the end of the lead wire by heat fusion, and the electrode head is integrated with electrode contacts for collecting ECG signals; the adhesive patch only serves as a skin adhesive barrier and does not contain a conductive electrode structure, the adhesive patch is detachably and retains its position on the electrode head, and can be replaced individually after a single use, while the electrode head can be repeatedly disinfected and reused.
[0011] Furthermore, the electrode head includes a base, a hollow capsule fixedly connected to the base, a plurality of electrode contacts integrally formed on the hollow capsule, and branch signal lines connected to each of the electrode contacts, the branch signal lines converging and connecting to the lead wire.
[0012] Furthermore, the electrode contacts are provided with a plurality of electrode microneedles that penetrate the stratum corneum of the skin, and the electrode microneedles form a sweating gap between them.
[0013] Furthermore, the length of the electrode microneedles is 10 micrometers to 20 micrometers.
[0014] Furthermore, both the electrode contacts and the electrode microneedles are made of titanium.
[0015] Furthermore, the base and the hollow bladder are integrally formed by a cylindrical rod, and the adhesive patch is positioned on the cylindrical rod for limiting.
[0016] Furthermore, the adhesive patch is centrally provided with an assembly hole adapted to the cylindrical rod. The adhesive patch extends radially outward from the assembly hole and is provided with a non-through die-cut assembly seam. When the adhesive patch is assembled onto the electrode head, the hollow capsule passes from behind the adhesive patch through the die-cut assembly seam to the front of the adhesive patch, so that the adhesive patch is located between the base and the hollow capsule. Subsequently, the electrode head slides along the die-cut assembly seam to the assembly hole, so as to use the assembly hole and the cylindrical rod to prevent the adhesive patch from falling off the electrode head.
[0017] Furthermore, a gasket is provided on one side of the hollow bladder located on the adhesive patch, the gasket being used to restrict the adhesive patch from sliding along the axial direction of the cylindrical rod.
[0018] Furthermore, the base, the hollow capsule, the cylindrical rod, and the pad are all integrally molded from medical-grade silicone.
[0019] Furthermore, the adhesive patch has no conductive layer and only has medical pressure-sensitive adhesive on one side.
[0020] The present invention has the following beneficial effects.
[0021] This invention integrates the functional structure of the electrocardiogram (ECG) signal acquisition electrode pads directly into the electrode head and sets it up as a single unit with the lead wires, eliminating the need for separate disposable electrode pads as in traditional methods. A detachable adhesive patch is also installed on the outside of the integrated electrode head. The adhesive patch only serves to adhere and fix the electrode to the skin and isolate it; it can be replaced individually depending on the usage scenario, individual patient, and aseptic requirements. The integrated electrode head is reusable. Compared to the traditional method of consuming 5 to 30 electrode pads per test, this invention only requires replacing the low-cost adhesive patch per test. In various scenarios such as clinical ECG monitoring, continuous vital sign monitoring, and Holter monitoring, there is no need to repeatedly replace a large number of disposable electrode pads, eliminating the problem of bulk consumable consumption. Each collection only requires replacing the low-cost adhesive patch, greatly reducing the procurement and operating costs of consumables for daily ECG monitoring in hospitals, effectively alleviating the medical cost burden on medical institutions, and avoiding the increase in patient medical costs due to the transfer of consumable costs. This optimizes the economics of clinical diagnosis and treatment and is suitable for the high-frequency usage needs of high-traffic medical scenarios such as outpatient clinics, inpatient wards, ICUs, and health checkup centers.
[0022] Meanwhile, the integrated design of the electrode pads and leads avoids the problems of loose contact, signal interference, and connection misalignment caused by repeated docking and fastening of traditional separate electrode pads and electrode clips. This ensures the stability and accuracy of ECG signal acquisition, effectively improving the reliability of ECG monitoring data and guaranteeing the accuracy of clinical diagnosis and monitoring. The overall structure is simple and compact, easy to assemble and disassemble, and highly reusable. Without compromising ECG monitoring performance or altering routine clinical procedures, it achieves cost reduction and efficiency improvement in ECG monitoring, effectively enhancing the utilization rate of medical resources and possessing strong practicality and application value. Attached Figure Description
[0023] To more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings used in the description of the embodiments will be briefly introduced below.
[0024] Figure 1 A three-dimensional electrocardiogram monitoring lead wire device that does not require disposable electrode pads is provided in the embodiments of this application. Figure 1 .
[0025] Figure 2 A three-dimensional electrocardiogram monitoring lead wire device that does not require disposable electrode pads is provided in the embodiments of this application. Figure 2 .
[0026] Figure 3 This is a cross-sectional perspective view of an electrocardiogram monitoring lead wire device that does not require disposable electrode pads, provided as an embodiment of this application.
[0027] Figure 4 An exploded view of an electrocardiogram monitoring lead wire device that does not require disposable electrode pads, provided in an embodiment of this application.
[0028] Figure 5 This is a schematic diagram of the structure of an electrocardiogram monitoring lead wire device that does not require disposable electrode pads after removing the adhesive patch, as provided in an embodiment of this application.
[0029] Figure 6 This is a schematic diagram of the electrode contact structure.
[0030] In the attached diagram: 1-lead wire, 101-signal wire core, 2-electrode head, 201-base, 202-hollow capsule, 203-electrode contact, 204-electrode microneedle, 205-cylindrical rod, 206-branch signal line, 3-adhesive patch, 301-die-cut assembly seam, 302-assembly round hole, 4-pad. Detailed Implementation
[0031] The technical solutions of the present invention will be described below with reference to the accompanying drawings. The described embodiments are only some embodiments of the present invention, and not all embodiments.
[0032] Please see Figures 1 to 6 As shown in the figure, this application provides a cardiac monitoring lead wire device that does not require disposable electrode pads. It is mainly applicable to various medical scenarios such as routine clinical electrocardiogram testing, continuous cardiac monitoring of hospitalized patients, intraoperative vital sign monitoring, and dynamic electrocardiogram monitoring. It can replace the traditional cardiac monitoring lead wire structure that requires disposable electrode pads, realizing reusable and low-consumable cardiac signal acquisition. The device mainly consists of three parts: lead wire 1, electrode head 2 with electrode contacts 203, and adhesive patch 3 that can be detachably assembled on electrode head 2. The various structures cooperate with each other, eliminating the traditional separate electrode pad and electrode clip connection structure, and optimizing the use effect and cost of cardiac monitoring from the structural source.
[0033] The lead wire 1 includes an insulating outer layer and a signal core 101 disposed inside the insulating outer layer. One end of the lead wire 1 is integrally formed with the electrode head 2 by heat fusion, resulting in a seamless connection with strong structural integrity, resistance to breakage, and stable signal transmission. The electrode head 2 is the core signal acquisition structure of the device, specifically including a base 201, a hollow capsule 202, electrode contacts 203, electrode microneedles 204, and branch signal lines 206, all integrally formed. The base 201 is located at the end of the lead wire 1 and is heat-fused to the insulating outer layer of the lead wire 1 to ensure the sealing and firmness of the connection. The base 201 is integrally connected to the hollow capsule 202 through a cylindrical rod 205, forming a continuous overall support structure with the base 201, cylindrical rod 205, and hollow capsule 202, providing a structural basis for the subsequent positioning, assembly, and bonding of the adhesive patch 3.
[0034] The hollow capsule 202 is designed as a flattened, round spherical structure. Multiple mounting holes are provided on the front of the capsule 202, and the electrode contacts 203 are embedded within these holes and thermally fused to the capsule 202 as a single unit. The contact surface is seamless and without any blind spots, resulting in a smooth and regular overall appearance. This design greatly facilitates infection control and disinfection procedures. Medical staff can directly perform comprehensive disinfection of the electrode contacts 203 and the capsule surface using conventional disinfection methods such as alcohol wiping and ozone sterilization, eliminating blind spots and meeting hospital aseptic treatment and infection control standards. Furthermore, the combination of the flattened, round spherical capsule and multiple distributed electrode contacts 203 ensures that even with slight body movement or skin displacement during ECG monitoring, the multi-contact structure maintains constant contact with the patient's skin, preventing single-point contact loosening or detachment. This, to a certain extent, guarantees the continuity and stability of ECG signal acquisition and reduces signal interruption and waveform distortion caused by slight body position changes.
[0035] Meanwhile, each electrode contact 203 surface is densely covered with a plurality of electrode microneedles 204. The electrode microneedles 204 and the electrode contact 203 are integrally formed, resulting in high structural strength and resistance to bending and detachment. In this embodiment, the length of the electrode microneedles 204 is strictly limited to 10 to 20 micrometers, preferably 20 micrometers. It is foreseeable that microneedles of 30 micrometers or longer are prone to touching superficial nerves in the skin, causing stinging discomfort to the patient; microneedles of 40 micrometers or longer can pierce the skin surface, causing bleeding, redness, and other damage. In contrast, the 20-micrometer electrode microneedles 204 of this invention only penetrate the stratum corneum of the skin, without touching nerves or capillaries, resulting in a painless and skin-damaging process with extremely high safety. Simultaneously, they can effectively penetrate the stratum corneum barrier, overcoming the insulating effect of the stratum corneum and ensuring the transmission of weak ECG signals, thus balancing safety and signal acquisition accuracy.
[0036] Furthermore, the microneedles 204 of each electrode have gaps, forming natural channels for ventilation, heat dissipation, and perspiration. Traditional disposable electrode pads are mostly integrally sealed adhesive structures with extremely poor skin breathability. During patient monitoring, sweat produced on the skin can easily cause the electrode pads to loosen, peel, or even fall off. At the same time, sweat residue can interfere with ECG signal acquisition, causing problems such as waveform drift and large data errors. This invention, through the perforated and breathable structure of the microneedle gaps, can, to a certain extent, wick away sweat and moisture from the skin surface, avoiding the problem of traditional electrode pads easily falling off due to sweat stains. It can also reduce the interference of sweat stains on ECG signal acquisition to a certain extent, improving the accuracy of monitoring. It is especially suitable for scenarios such as long-term dynamic ECG monitoring and continuous monitoring of critically ill patients.
[0037] In this invention, both the electrode contact 203 and the electrode microneedle 204 are made of titanium, which possesses excellent biocompatibility and conductivity. Traditional disposable electrode pads often contain chemical conductive additives such as chlorides in their conductive areas. Long-term or frequent contact with human skin can easily cause adverse reactions such as skin allergies, itching, blistering, and redness, making them unsuitable for patients with sensitive constitutions. This device, however, uses pure titanium as the main material for signal acquisition. It has no chemical conductive coating and no irritating chemical components, eliminating the risk of skin irritation from chemicals and effectively preventing skin allergies. This improves the safety and comfort of ECG monitoring. Furthermore, titanium has stable conductivity, no conductivity attenuation issues, and can be reused repeatedly for extended periods with consistent signal acquisition performance.
[0038] In this device, the adhesive patch 3 is the only replaceable consumable, employing a detachable limiting assembly structure adapted to the reusable electrode head 2. Specifically, the adhesive patch 3 has an assembly hole 302 at its center that matches the cylindrical rod 205. A die-cut assembly seam 301 extends radially outward from the assembly hole 302 on the adhesive patch 3. The die-cut assembly seam 301 is not radially continuous but axially extends through the adhesive patch 3. In actual assembly and use, the hollow capsule 202 is first inserted from the rear of the adhesive patch 3 through the die-cut assembly seam 301 to the front of the adhesive patch 3, initially placing the adhesive patch 3 in the assembly area between the base 201 and the hollow capsule 202. Then, the electrode head 2 is pushed to slide along the die-cut assembly seam 301, precisely engaging the cylindrical rod 205 inside the assembly hole 302, completing the limiting assembly of the adhesive patch 3 and the electrode head 2. Once the adhesive patch 3 is completely adhered and fixed to the surface of human skin, the die-cut assembly seam 301 will be completely sealed by the adhesive layer, preventing the gap from expanding outward. This firmly restricts the relative displacement between the cylindrical rod 205 and the assembly hole 302, ensuring that the adhesive patch 3 is tightly locked to the electrode head 2. During the monitoring process, there will be no situation where the patch becomes loose, falls off, or shifts.
[0039] Meanwhile, an annular pad 4 is provided on the side of the hollow capsule 202 near the adhesive patch 3. The pad 4 is integrally formed with the hollow capsule 202 and can form an axial limiting block for the adhesive patch 3, effectively preventing the adhesive patch 3 from sliding along the cylindrical rod 205 axially, further improving the stability of the overall assembly structure, and ensuring that the electrode microneedle 204 remains in contact with the skin during the monitoring process.
[0040] In this embodiment, the base 201, cylindrical rod 205, hollow bladder 202, and pad 4 are all integrally molded from medical-grade silicone. Medical-grade silicone is soft and conforms well, which can further adapt to the curvature of human skin and improve wearing comfort. At the same time, silicone is tough, resistant to disinfection, and not easy to age. It can be repeatedly cleaned with ultrasonic cleaning, alcohol wiping, and ozone disinfection, which fully meets the disinfection requirements for clinical infection control and will not cause cracking, deformation, aging and failure due to repeated disinfection.
[0041] Regarding overall infection control and reusability, this invention integrates the lead wire and electrode head into a single, heat-fused design, eliminating seams and unsanitary corners. The adhesive patch isolates the patient's sweat and bodily fluids, allowing for direct disposal after each monitoring session. The electrode head only contacts the back of the patch, with minimal or no direct contact with bodily fluids. Standard ultrasonic cleaning combined with alcohol wiping and ozone disinfection is sufficient to meet requirements. The disinfection method and standards are identical to traditional reusable ECG electrode heads, requiring no special disinfection equipment or procedures, and are compatible with existing hospital infection control systems. Compared to traditional monitoring methods that consume disposable electrode pads throughout the entire process, this device only requires replacing the low-cost adhesive patch to meet aseptic requirements, significantly reducing medical consumable consumption. It addresses the industry pain points of traditional ECG monitoring, such as high consumption, high cost, allergies, and signal interference, balancing clinical safety, accuracy, and economy, making it suitable for widespread application in medical institutions at all levels.
[0042] In summary, the embodiments of this application provide an ECG monitoring lead wire device that does not require disposable electrode pads, and has at least the following advantages:
[0043] First, traditional single-session monitoring requires the replacement of at least 5 to 30 conductive electrodes, while this solution only replaces adhesive patches without a conductive layer, reducing the cost of consumables per patient by more than 70%, resulting in a significant cost reduction. Second, the electrode contacts and microneedles are made of pure titanium, without any chemical conductive gel, significantly reducing the incidence of skin allergies; the 10 to 20 μm microneedles only penetrate the stratum corneum, causing no pain or skin breakage, and the gaps between the microneedles allow for ventilation and sweating, alleviating the problems of skin stuffiness, redness, and swelling during long-term monitoring.
[0044] Third, the leads and electrode heads are integrally molded without any contact breaks. The multi-contact distributed structure prevents antibody swaying and ensures signal stability. The breathable structure formed between the microneedles reduces the risk of waveform drift caused by sweat.
[0045] Fourth, the adhesive patch and electrode head are assembled using a die-cut seam and round hole limiting assembly, which is simple to disassemble and use. After pasting, the gap is self-locking. Combined with the pad design, it reduces the risk of the electrode head shifting and falling off during measurement.
[0046] In summary, the embodiments of this application provide an ECG monitoring lead wire device that does not require disposable electrode pads. It adopts a structural design of silicone hollow capsule with an adaptable curved surface, multi-contact titanium microneedles to reduce impedance, and die-cut patch to achieve sterile, low-cost reusability. The three elements work together to solve multiple pain points such as cost, allergies, signal, and hospital infection, and have four major advantages: low cost, low allergy, stable signal, and hospital infection safety.
[0047] The above-described embodiments are merely preferred embodiments of the present invention and not limitations. Those skilled in the art should understand that the scope of protection of the present invention is not limited thereto. Any equivalent substitutions or modifications made by those skilled in the art within the scope of the technology disclosed in the present invention without departing from the technical solution and inventive concept of the present invention should be covered within the scope of protection of the present invention.
Claims
1. A cardiac monitoring lead wire device that does not require disposable electrode pads, characterized in that: The device includes a lead wire, an electrode head, and an adhesive patch. The electrode head is integrally formed with the end of the lead wire by heat fusion, and the electrode head integrates electrode contacts for collecting electrocardiogram signals. The adhesive patch only serves as a skin adhesive barrier and does not contain a conductive electrode structure. The adhesive patch is detachably and securely attached to the electrode head and can be replaced individually after each use. The electrode head can be repeatedly disinfected and reused.
2. The ECG monitoring lead wire device that does not require disposable electrode pads according to claim 1, characterized in that: The electrode head includes a base, a hollow capsule fixedly connected to the base, a plurality of electrode contacts integrally formed on the hollow capsule, and branch signal lines connected to each of the electrode contacts. The branch signal lines converge and connect to the lead wire.
3. The ECG monitoring lead wire device that does not require disposable electrode pads according to claim 2, characterized in that: The electrode contacts are provided with a number of electrode microneedles that penetrate the stratum corneum of the skin, and the electrode microneedles form a sweating gap between them.
4. The ECG monitoring lead wire device that does not require disposable electrode pads according to claim 3, characterized in that: The length of the electrode microneedles is 10 to 20 micrometers.
5. The ECG monitoring lead wire device that does not require disposable electrode pads according to claim 3, characterized in that: Both the electrode contacts and the electrode microneedles are made of titanium.
6. The ECG monitoring lead wire device that does not require disposable electrode pads according to claim 2, characterized in that: The base and the hollow bladder are integrally formed by a cylindrical rod, and the adhesive patch is positioned on the cylindrical rod for limiting.
7. The ECG monitoring lead wire device that does not require disposable electrode pads according to claim 6, characterized in that: The adhesive patch has a centrally located mounting hole that matches the cylindrical rod. A non-through die-cut assembly seam extends radially outward from the mounting hole. When the adhesive patch is assembled onto the electrode head, the hollow capsule passes through the die-cut assembly seam from behind the adhesive patch to the front of the adhesive patch, positioning the adhesive patch between the base and the hollow capsule. The electrode head then slides along the die-cut assembly seam to the mounting hole, whereby the mounting hole, in conjunction with the cylindrical rod, prevents the adhesive patch from detaching from the electrode head.
8. The ECG monitoring lead wire device that does not require disposable electrode pads according to claim 7, characterized in that: The hollow capsule has a gasket on one side of the adhesive patch, and the gasket is used to restrict the adhesive patch from sliding along the axial direction of the cylindrical rod.
9. The ECG monitoring lead wire device that does not require disposable electrode pads according to claim 8, characterized in that: The base, the hollow capsule, the cylindrical rod, and the liner are all integrally molded from medical-grade silicone.
10. The ECG monitoring lead wire device that does not require disposable electrode pads according to claim 1, characterized in that: The adhesive patch has no conductive layer and only has medical pressure-sensitive adhesive on one side.
